Covered recipient · General Payments record
CARLY LANE OVERGARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,039.49
- Reported across 340 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $581.36 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $413.13 | 26 |
| DEXCOM, INC. | $137.87 | 9 |
| Acerta Pharma LLC | $30.36 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.07 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105829701 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.29 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104481478 | CMS |
| Dexcom, Inc. | $21.17 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353158 | CMS |
| Dexcom, Inc. | $3.78 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353160 | CMS |
| Dexcom, Inc. | $2.27 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353162 | CMS |
| Dexcom, Inc. | $17.61 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353164 | CMS |
| Dexcom, Inc. | $20.39 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353166 | CMS |
| Dexcom, Inc. | $4.35 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353168 | CMS |
| Dexcom, Inc. | $29.18 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353170 | CMS |
| Dexcom, Inc. | $3.79 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353172 | CMS |
| Dexcom, Inc. | $35.33 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353174 | CMS |
| Novo Nordisk Inc | $20.11 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100341866 | CMS |
| Novo Nordisk Inc | $20.54 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100289164 | CMS |
| Novo Nordisk Inc | $15.08 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100489579 | CMS |
| Novo Nordisk Inc | $10.76 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100390524 | CMS |
| Novo Nordisk Inc | $12.77 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100428455 | CMS |
| Novo Nordisk Inc | $22.48 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100473916 | CMS |
| Novo Nordisk Inc | $11.94 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100313845 | CMS |
| Novo Nordisk Inc | $17.86 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100578348 | CMS |
| Novo Nordisk Inc | $16.32 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497259 | CMS |
| Novo Nordisk Inc | $16.74 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100493673 | CMS |
| Novo Nordisk Inc | $19.38 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100587129 | CMS |
| Novo Nordisk Inc | $17.56 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100289220 | CMS |
| Novo Nordisk Inc | $6.59 | 07/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100437421 | CMS |
| Novo Nordisk Inc | $23.25 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100628074 | CMS |
| Novo Nordisk Inc | $19.86 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100334732 | CMS |
| Novo Nordisk Inc | $13.61 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100617960 | CMS |
| Novo Nordisk Inc | $16.40 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100598421 | CMS |
| Novo Nordisk Inc | $13.36 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100244057 | CMS |
| Novo Nordisk Inc | $16.13 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100446837 | CMS |
| Novo Nordisk Inc | $9.39 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100473684 | CMS |
| Novo Nordisk Inc | $13.81 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100403561 | CMS |
| Novo Nordisk Inc | $6.96 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100394578 | CMS |
| Novo Nordisk Inc | $15.97 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100600669 | CMS |
| Novo Nordisk Inc | $21.13 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100544532 | CMS |
| Novo Nordisk Inc | $15.04 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382833 | CMS |
| Novo Nordisk Inc | $20.09 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100387031 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.